Annual Operating Profit
-$15.77 M
-$3.09 M-24.39%
December 31, 2023
Summary
- As of February 7, 2025, ENTO annual operating income is -$15.77 million, with the most recent change of -$3.09 million (-24.39%) on December 31, 2023.
- During the last 3 years, ENTO annual operating profit has risen by +$10.66 million (+40.34%).
- ENTO annual operating profit is now -233.51% below its all-time high of -$4.73 million, reached on December 1, 2015.
Performance
ENTO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$1.89 M
+$1.53 M+44.76%
September 1, 2024
Summary
- As of February 7, 2025, ENTO quarterly operating income is -$1.89 million, with the most recent change of +$1.53 million (+44.76%) on September 1, 2024.
- Over the past year, ENTO quarterly operating profit has increased by +$2.20 million (+53.77%).
- ENTO quarterly operating profit is now -143.12% below its all-time high of $4.39 million, reached on September 1, 2022.
Performance
ENTO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$18.64 M
+$1.54 M+7.63%
September 1, 2024
Summary
- As of February 7, 2025, ENTO TTM operating income is -$18.64 million, with the most recent change of +$1.54 million (+7.63%) on September 1, 2024.
- Over the past year, ENTO TTM operating profit has dropped by -$2.87 million (-18.18%).
- ENTO TTM operating profit is now -1637.97% below its all-time high of -$1.07 million, reached on March 1, 2015.
Performance
ENTO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ENTO Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -24.4% | +53.8% | -18.2% |
| 3 y3 years | +40.3% | +53.4% | -153.3% |
| 5 y5 years | -17.4% | +53.6% | -42.6% |
ENTO Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -24.4% | +72.2% | -143.1% | +79.8% | -203.8% | +67.8% |
| 5 y | 5-year | -24.4% | +72.2% | -143.1% | +93.8% | -203.8% | +71.5% |
| alltime | all time | -233.5% | +72.2% | -143.1% | +93.8% | -1638.0% | +71.5% |
Entero Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.89 M(-44.8%) | -$18.64 M(-7.6%) |
| Jun 2024 | - | -$3.43 M(-62.9%) | -$20.18 M(-3.6%) |
| Mar 2024 | - | -$9.23 M(+125.4%) | -$20.93 M(+32.7%) |
| Dec 2023 | -$15.77 M(+24.4%) | -$4.09 M(+19.2%) | -$15.77 M(+13.0%) |
| Sep 2023 | - | -$3.43 M(-17.9%) | -$13.96 M(+127.5%) |
| Jun 2023 | - | -$4.18 M(+2.9%) | -$6.13 M(-16.6%) |
| Mar 2023 | - | -$4.06 M(+78.2%) | -$7.36 M(-42.0%) |
| Dec 2022 | -$12.68 M(-77.6%) | - | - |
| Dec 2022 | - | -$2.28 M(-151.9%) | -$12.68 M(-34.0%) |
| Sep 2022 | - | $4.39 M(-181.2%) | -$19.21 M(-64.4%) |
| Jun 2022 | - | -$5.41 M(-42.4%) | -$54.00 M(-6.7%) |
| Mar 2022 | - | -$9.38 M(+6.4%) | -$57.87 M(+2.1%) |
| Dec 2021 | -$56.70 M(+114.5%) | -$8.81 M(-71.0%) | -$56.70 M(-13.1%) |
| Sep 2021 | - | -$30.40 M(+227.7%) | -$65.29 M(+69.1%) |
| Jun 2021 | - | -$9.28 M(+12.9%) | -$38.60 M(+21.7%) |
| Mar 2021 | - | -$8.21 M(-52.8%) | -$31.72 M(+20.0%) |
| Dec 2020 | -$26.43 M(+79.3%) | -$17.40 M(+368.7%) | -$26.43 M(+160.2%) |
| Sep 2020 | - | -$3.71 M(+55.1%) | -$10.16 M(-3.5%) |
| Jun 2020 | - | -$2.39 M(-18.3%) | -$10.53 M(-19.4%) |
| Mar 2020 | - | -$2.93 M(+160.1%) | -$13.07 M(-11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2019 | -$14.74 M(+9.8%) | -$1.13 M(-72.4%) | -$14.74 M(-16.4%) |
| Sep 2019 | - | -$4.08 M(-17.2%) | -$17.64 M(+9.4%) |
| Jun 2019 | - | -$4.93 M(+7.1%) | -$16.12 M(+11.6%) |
| Mar 2019 | - | -$4.60 M(+14.6%) | -$14.45 M(+7.6%) |
| Dec 2018 | -$13.43 M(+31.4%) | -$4.02 M(+56.6%) | -$13.43 M(+13.6%) |
| Sep 2018 | - | -$2.57 M(-21.4%) | -$11.83 M(-3.4%) |
| Jun 2018 | - | -$3.26 M(-9.0%) | -$12.24 M(+10.3%) |
| Mar 2018 | - | -$3.58 M(+48.6%) | -$11.10 M(+7.5%) |
| Dec 2017 | -$10.22 M(+54.3%) | -$2.41 M(-19.0%) | -$10.32 M(+1.4%) |
| Sep 2017 | - | -$2.98 M(+40.1%) | -$10.17 M(+19.9%) |
| Jun 2017 | - | -$2.12 M(-24.4%) | -$8.49 M(+4.9%) |
| Mar 2017 | - | -$2.81 M(+24.0%) | -$8.09 M(+22.1%) |
| Dec 2016 | -$6.63 M(+40.1%) | -$2.26 M(+75.8%) | -$6.63 M(+40.1%) |
| Sep 2016 | - | -$1.29 M(-25.3%) | -$4.73 M(-2.5%) |
| Jun 2016 | - | -$1.73 M(+28.0%) | -$4.85 M(-3.1%) |
| Mar 2016 | - | -$1.35 M(+265.3%) | -$5.00 M(+5.8%) |
| Dec 2015 | -$4.73 M | -$368.80 K(-73.8%) | -$4.73 M(+8.5%) |
| Sep 2015 | - | -$1.41 M(-25.0%) | -$4.36 M(+47.7%) |
| Jun 2015 | - | -$1.88 M(+75.2%) | -$2.95 M(+175.2%) |
| Mar 2015 | - | -$1.07 M | -$1.07 M |
FAQ
- What is Entero Therapeutics annual operating income?
- What is the all time high annual operating profit for Entero Therapeutics?
- What is Entero Therapeutics annual operating profit year-on-year change?
- What is Entero Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Entero Therapeutics?
- What is Entero Therapeutics quarterly operating profit year-on-year change?
- What is Entero Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Entero Therapeutics?
- What is Entero Therapeutics TTM operating profit year-on-year change?
What is Entero Therapeutics annual operating income?
The current annual operating profit of ENTO is -$15.77 M
What is the all time high annual operating profit for Entero Therapeutics?
Entero Therapeutics all-time high annual operating income is -$4.73 M
What is Entero Therapeutics annual operating profit year-on-year change?
Over the past year, ENTO annual operating income has changed by -$3.09 M (-24.39%)
What is Entero Therapeutics quarterly operating income?
The current quarterly operating profit of ENTO is -$1.89 M
What is the all time high quarterly operating profit for Entero Therapeutics?
Entero Therapeutics all-time high quarterly operating income is $4.39 M
What is Entero Therapeutics quarterly operating profit year-on-year change?
Over the past year, ENTO quarterly operating income has changed by +$2.20 M (+53.77%)
What is Entero Therapeutics TTM operating income?
The current TTM operating profit of ENTO is -$18.64 M
What is the all time high TTM operating profit for Entero Therapeutics?
Entero Therapeutics all-time high TTM operating income is -$1.07 M
What is Entero Therapeutics TTM operating profit year-on-year change?
Over the past year, ENTO TTM operating income has changed by -$2.87 M (-18.18%)